➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Johnson and Johnson

Last Updated: August 12, 2020

DrugPatentWatch Database Preview

Oxytocin - Generic Drug Details

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What are the generic sources for oxytocin and what is the scope of patent protection?

Oxytocin is the generic ingredient in six branded drugs marketed by Dr Reddys, Fresenius Kabi Usa, Hikma Farmaceutica, Sagent Pharms Inc, West-ward Pharms Int, Abbott, Par Sterile Products, Novartis, and Rtrx, and is included in nine NDAs. Additional information is available in the individual branded drug profile pages.

There are eleven drug master file entries for oxytocin. Five suppliers are listed for this compound.

Drug Prices for oxytocin

See drug prices for oxytocin

Recent Clinical Trials for oxytocin

Identify potential brand extensions & 505(b)(2) entrants

Wake Forest University Health SciencesPhase 2
KK Women's and Children's HospitalPhase 3
University of ParmaPhase 2

See all oxytocin clinical trials

Pharmacology for oxytocin
Medical Subject Heading (MeSH) Categories for oxytocin

US Patents and Regulatory Information for oxytocin

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Par Sterile Products PITOCIN oxytocin INJECTABLE;INJECTION 018261-003 Sep 5, 2012 RX Yes No   Start Trial   Start Trial   Start Trial
Hikma Farmaceutica OXYTOCIN oxytocin INJECTABLE;INJECTION 200219-001 Feb 13, 2013 AP RX No No   Start Trial   Start Trial   Start Trial
Dr Reddys OXYTOCIN oxytocin INJECTABLE;INJECTION 077453-001 Jan 24, 2008 DISCN No No   Start Trial   Start Trial   Start Trial
West-ward Pharms Int OXYTOCIN oxytocin INJECTABLE;INJECTION 018243-001 Approved Prior to Jan 1, 1982 AP RX Yes Yes   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Boehringer Ingelheim
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.